Encorafenib, Binimetinib, and Cetuximab in BRAF V600E-Mutated Colorectal Cancer

N Engl J Med. 2020 Feb 27;382(9):876. doi: 10.1056/NEJMc1915676.
No abstract available

Publication types

  • Letter
  • Comment

MeSH terms

  • Benzimidazoles
  • Carbamates
  • Cetuximab
  • Colorectal Neoplasms*
  • Humans
  • Proto-Oncogene Proteins B-raf*
  • Sulfonamides

Substances

  • Benzimidazoles
  • Carbamates
  • Sulfonamides
  • binimetinib
  • encorafenib
  • BRAF protein, human
  • Proto-Oncogene Proteins B-raf
  • Cetuximab